Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)309
Editorial Board189
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis153
Susac syndrome: A scoping review148
Endometriosis and autoimmunity118
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review112
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis97
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective96
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence88
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management85
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review84
“Fibromyalgia syndrome” related to Essure devices78
Leflunomide: A safe and effective alternative in systemic lupus erythematosus78
Editorial Board77
Editorial Board77
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch76
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives76
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders74
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases71
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 2470
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate70
Can anticoagulation be withdrawn in APS patients after aPL negativization?65
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis63
STING-inflammasome axis in autoimmune diseases and inflammation-related disease61
Psychiatric manifestations of autoimmune encephalitis60
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction57
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination54
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology 54
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.52
Editorial Board52
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes52
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned51
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases50
Seronegative autoimmune diseases: A challenging diagnosis48
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy48
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy46
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 202145
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature45
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases45
Autoimmune pre-disease45
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease45
Autoimmunity in vitiligo: Therapeutic implications and opportunities44
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered44
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review43
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis43
Editorial Board43
0.18924307823181